Nov. 20, 2026: National Advocacy Update

| 13 Min Read

CMS releases roadmap on clinical "super intelligence"

On Nov. 13, the Centers for Medicare & Medicaid Services (CMS) released A Clinical Super Intelligence Roadmap: Better Answers, Faster Care, and Lower Costs (PDF), detailing priorities and guiding principles to make clinical artificial or augmented intelligence (AI), referred to by the federal government as clinical “super intelligence” (SI), available for patients. It outlines the roles of government and industry to expand access to safe, effective, affordable, and trustworthy clinical SI. 

General email newsletter lean icon
Haven't subscribed?
Stay current on the latest issues impacting physicians, patients and healthcare with the AMA’s Advocacy Update newsletter.

The roadmap will prioritize developing: (1) public trust; (2) an interoperable foundation for data; (3) clear regulations and standards; and (4) payment models or pathways for clinical SI tools that enhance outcomes and reduce costs. Guiding principles include:  

  1. Establishing safety and reliability by holding clinical SI to a “better than today” standard 
  2. Building toward earned adoption through phased deployment, evidence, human oversight and real-world monitoring 
  3. Increasing patient control of their own health data and decisions, including that patients should know and consent to use of their health data in SI 
  4. Prioritizing SI technologies and payment models that decrease cost while increasing access to care 
  5. Creating permanent market access pathways 

CMS acknowledges the need for trusted data exchange for the expansion of clinical SI (noting that HHS will make efforts to improve data interoperability for patients, clinicians, and payers through the CMS Aligned Networks and Health Tech Ecosystem) as well as the need for FDA-CMS partnership in improving postmarket surveillance mechanisms. 

Initiatives include continued support for a faster market path for low-risk tools for consumer wellness and clinical decision support under current FDA guidance; a risk- and competency-based approach to premarket evaluation of some SI-enabled devices that is similar to how physicians are evaluated; real-world, postmarket monitoring with predetermined change control plans; collaborating with states on SI sandboxes; advising on SI-enabled direct-access pathways for certain products; and clarifying liability and risk for the adoption of AI tools. 

CMS will focus on payment for AI tools that improve clinical outcomes and lower costs. CMS plans to: (1) expand the Advancing Chronic Care with Effective, Scalable Solutions (ACCESS) model and ACCESS-aligned payment approaches; (2) encourage SI developers to improve preventive care; (3) enable “SI-led solutions” to participate in CMS Innovation Center models for primary care and total cost of care management while exploring broader primary care payment reform; (4) promote “clinical SI-led options” in the Marketplaces and Medicare Advantage; and (5) partner with states to accelerate, evaluate and validate alternative payment arrangements. 

AMA summaries: 2027 Medicare payment rules

On Nov. 4, the Centers for Medicare & Medicaid Services (CMS) released the calendar year (CY) 2027 final rules for the Medicare Physician Fee Schedule (PFS) and Quality Payment Program (QPP) (PDF), the Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center (ASC) Payment System (PDF), and the Home Health Prospective Payment System (PDF). Physicians face a 2.31% cut to the conversion factor in 2027. The AMA is urging Congress to pass the bipartisan Patients First Act (H.R. 9693), which would establish an annual inflation-based update for physicians. Summaries of each rule follow. 

Medicare Physician Fee Schedule and Quality Payment Program

View the complete AMA summary (PDF). Key provisions are outlined as follows.  

The 2027 conversion factor will fall by 2.31%, to $32.6286, for most physicians, and by 1.83%, to $32.9548, for those in qualifying alternative payment models (APMs). The cut comes primarily from the expiration of a temporary 2.5% increase, while CMS projects that the cost of running a practice will rise 2.6%. 

Key provisions include: 

  • Modifier 25: Following advocacy by the AMA and more than 150 medical organizations, CMS significantly scaled back its proposed cut to same-day office visits and procedures. Instead of cutting payment by 50 percent for 0-, 10-, and 90-day global procedures, CMS will cut payment by 20 percent and only for 0-day global procedures furnished by the same physician or a physician of the same specialty in the same group. The AMA continues to oppose the policy. We are pressing Congress to act during lame duck to delay implementation of the policy for one year.  
  • Remote monitoring: CMS finalized requirements for an initiating visit and an established patient relationship for both remote physiologic and remote therapeutic monitoring. CMS delayed until 2029 its requirement that these services be furnished only by practice-employed clinical staff. CMS finalized payment cuts for device supply codes, but, as the AMA urged, did not eliminate practice expense payment for treatment management services. CMS also did not adopt new G-codes that would have bundled remote monitoring services. The AMA RVS Update Committee (RUC) will review all remote monitoring codes in Jan. 2027. 
  • MIPS Value Pathways (MVPs): Thanks in part to AMA advocacy, CMS delayed mandatory MVP reporting by two years, until the 2031 performance period. The AMA continues to call for voluntary reporting and measures that reflect the care physicians provide. 
  • Electronic prior authorization (PA): Following AMA advocacy, CMS made the electronic PA measure optional in 2027, with bonus points for practices ready to participate, before it becomes required in 2028. 
  • Reduced paperwork: CMS adopted AMA-backed changes to eliminate unnecessary paperwork, including electronic health record attestations and duplicate security reporting. 
  • Value-based care incentives: Despite AMA opposition, CMS will cut physician incentives for Alternative Payment Model participation by an estimated $2.4 billion over 10 years, potentially discouraging future participation, particularly among smaller and specialty practices. 
  • Maternity Care Services CPT codes: The AMA is pleased CMS finalized the revised Maternity Care Services CPT codes, which take effect on Jan. 1. The American Health Insurance Plans (AHIP) had pressured CMS to adopt HCPCS-G codes. The AMA worked closely with the American College of Gynecologists to urge CMS to the CPT code set without parallel G-codes, noting that two coding structures would create confusion and administrative burden for care teams and patients. The new codes reflect modern obstetric practice and will provide much-needed transparency for patients and more granular data to help physicians and researchers better understand the drivers of maternal mortality. 

Hospital Outpatient and ASC Payment Systems

View the complete AMA summary (PDF). Key provisions are outlined as follows.  

CMS finalized a 2.3% payment update for hospital outpatient departments (HOPDs) and ASCs. 

Key provisions include: 

  • Site neutral payment for imaging: Over AMA objections, CMS will pay for imaging services without contrast furnished in grandfathered off-campus HOPDs at the Medicare Physician Fee Schedule equivalent rate, outside of budget neutrality. The policy removes an estimated $260 million from Medicare in 2027, rather than reinvesting those savings in Part B services, including physician payment, as the AMA urged. Rural sole community hospitals are exempt. 
  • Inpatient Only (IPO) list: CMS removed 637 services across 11 clinical families in the second phase of eliminating the IPO list. The remaining cardiovascular, neurological and transplant procedures are slated for removal in 2028. 
  • PA for botulinum toxin injections: Despite AMA concerns, CMS will require PA for eight additional botulinum toxin injection codes in HOPDs beginning July 1, 2027. 
  • 340B drug payment: CMS will pay for 340B-acquired drugs at average sales price (ASP) minus 28%, rather than the proposed ASP minus 33.4%, citing commenters’ concerns that the steeper cut could limit patient access. Because the change must be budget neutral, CMS will raise OPPS payments for other services by an estimated 7.5%. 
  • ASC payments: As the AMA supported, CMS will continue to update ASC payments using the hospital market basket for one more year. However, it again declined to eliminate the ASC scaler, which falls in 2027 largely because of the 340B policy. 

Home Health: Medicare enrollment provisions affecting physicians 

The home health final rule matters to physicians because of its Medicare enrollment provisions, which apply to nearly all physicians and physician practices. In response to concerns raised by the AMA and others, CMS dropped two of the most far-reaching proposals. One would have let CMS revoke all of a physician’s Medicare enrollments based on the denial of a single application. The other would have allowed denial of enrollment based on a debt or payment suspension involving any party with a business or financial relationship with the practice. However, over AMA objections, CMS finalized most of the remaining provisions without change. These make all revocations retroactive, add new grounds for revocation or denial (including certain misdemeanor convictions and a practice’s location or shared office space), and shorten the window for filing claims after a revocation from 60 to 15 days. CMS also declined to re-propose the provisions in the PFS rule, where physicians would expect to find them. The provisions take effect in early Jan. 2027, and the AMA will continue to press CMS for guidance and safeguards that protect physicians acting in good faith. 

New "batching" rules for surprise billing claims begin this month

On June 4, the administration released a long-anticipated final rule to improve the functioning of the Federal Independent Dispute Resolution (IDR) process established under the No Surprises Act (NSA). The rule reflected many previous AMA recommendations (PDF)and was broadly considered a win for physicians. Among other changes, the rule included additional flexibilities for batching items and services into a single dispute, including extending the number of allowed line items from 25 to 50 and shortening the “cooling off period” from 90 to 30 days for batched claims. New batching requirements under the rule are now taking effect for items and services with open negotiation periods beginning on/after Nov. 1. In preparation, the administration recently issued new guidance (PDF).  

The guidance primarily details examples of what would constitute a similar item or service and how timing for submission of batched claims relates to cooling off periods. It also clarifies that service code modifiers and anesthesia qualifying circumstances add-on codes that function as modifiers will not count toward the 50-line-item limit. Finally, according to the guidance, parties will also no longer be able to resubmit improperly batched disputes. Moving forward, Certified IDR entities who determine a dispute to be inappropriately batched are instead directed to proceed with rendering payment determinations for the items or services that are found to be properly batched. Questions should be directed to [email protected] or the No Surprises Help Desk at 1-800-985-3059. 

Surprise billing disputes move to online gateway

On Nov. 13, the Federal Independent Dispute Resolution (IDR) process transitioned from single-use web forms to the new IDR Gateway, a centralized online platform to manage disputes. Organizations with IDR Gateway accounts can now submit “Notice of IDR Initiation,” “Notice of IDR Initiation Response,” “Notice of Certified IDR Entity Selection,” and “Notice of Offer” web forms through the Gateway. The web forms will no longer be available outside the IDR Gateway after Jan. 15, 2027. To continue using the Federal IDR process after that date, users must create an IDR Gateway account. CMS anticipates that processing these forms through the Gateway will boost compliance. Additional Gateway functionalities including dedicated features for open negotiations are slated for release through 2027. For more information, visit the IDR Gateway page or email [email protected] or call 1-800-985-3059. 

AMA-supported Preventive Health Savings Act passes House of Representatives

The ongoing effort to enable Congress to pass more preventive healthcare bills took a major step forward on Nov. 19 following the House of Representatives passing H.R. 4464, the Preventive Health Savings Act. Introduced by Reps. Jay Obernolte (R-CA), Scott Peters (D-CA), Diana DeGette (D-CO) and Buddy Carter (R-GA), this bipartisan legislation enables leaders in Congress to request the Congressional Budget Office (CBO) to provide an estimate of the long-term health savings that derive from preventive health initiatives. Since the House Budget Committee advanced the bill unanimously in September, the legislation was considered by the full House of Representatives under “suspension of the rules,” a parliamentary maneuver that enables non-controversial, widely supported measures to more easily pass the lower chamber. The final House vote was 401 to 0.

Under H.R. 4464, the chair and ranking member of the budget and health-related committees in the House or Senate are permitted to jointly request a CBO analysis of the two 10-year periods, beyond the existing initial 10-year window. CBO’s use of a single 10-year “scoring window” often results in the majority of preventive health services and screening procedures being assessed as a short-term increase to the Medicare program simply because they are new types of care available to patients. This myopic economic analysis, however, misses the potential for preventive healthcare to actually save money over the long-term due to its ability to catch diseases and other conditions at their earliest stage. Early detection or diagnosis enables physicians to actually treat or cure many conditions, thus leading to long-term, downstream savings that are often not captured by current CBO assessment methodologies.   

The AMA is a long-term supporter of this legislation and sent two letters endorsing H.R. 4464 in August (PDF) and September (PDF) 2025, respectively. In addition, the AMA sent a letter (PDF) thanking the budget committee for advancing the Preventive Health Savings Act out of Committee in Sept. 2026. The AMA most recently sent a letter of support in advance of full passage through the House of Representatives and will push the Senate to expeditiously pass this legislation before the end of the 119th Congress. 

Reminder: 2027 MIPS payment adjustments released; targeted reviews due by Nov. 30

CMS has released 2027 Merit-based Incentive Payment System (MIPS) payment adjustments based off 2025 MIPS performance period data. 2025 MIPS scores determine 2027 payment adjustments. The AMA urges all physicians and group practices to sign in to the Quality Payment Program (QPP) website to review their performance and payment adjustment information to ensure correct calculations. If an EC or group practice believes CMS calculated their final score or 2027 payment adjustment incorrectly, they must file a targeted review with CMS by Nov. 30. 

Examples of circumstances that could prompt a Targeted Review include:  

  • Data were submitted under the wrong TIN or National Provider Identifier (NPI).  

  • You have Qualifying APM Participant (QP) status and shouldn’t receive a MIPS payment adjustment.  

  • Performance categories weren’t automatically reweighted even though you qualify for reweighting due to extreme and uncontrollable circumstances. (Learn more in the 2025 MIPS Automatic Extreme and Uncontrollable Circumstances Fact Sheet (PDF).)  

CMS generally requires documentation to support a targeted review request, which varies by circumstance. A CMS representative will contact you about providing any specific documentation required. If the targeted review request is approved and results in a scoring change, we’ll update your final score and/or associated payment adjustment (if applicable), as soon as technically feasible.  2025 Targeted Review User Guide (PDF)—Reviews the process for requesting a targeted review and examples for when you would or wouldn’t request a targeted review.  Please note that targeted review decisions are final and not eligible for further review. 

Your Powerful Ally
Through AMA advocacy and policymaking, we are addressing the issues important to you—together—and shaping what’s next for physicians.

FEATURED STORIES

Man power walking or jogging, with dumbbells

New changes expand diabetes-prevention for more Medicare patients

| 3 Min Read
Three healthcare workers in discussion

AMA Joy in Medicine points the way to better care

| 5 Min Read
Doctors hold up magnifying glasses over a giant pancreas

Beyond watch and wait: Taking aim at pancreatic cysts

| 7 Min Read
Philip Kuriakose, MD, featured on "Health vs. Hype" AMA podcast

5 things patients should know about microplastics

| 8 Min Read